Further cuts at embattled theranostics firm PharmaNetics
This article was originally published in Clinica
Executive Summary
PharmaNetics, the tiny firm focused on technology that can be used by doctors to monitor the effect of anti-clotting drugs on individual patients and adjust the therapy accordingly, has cut its workforce by 17 to 38 people.